SRTS earnings date and last-quarter result: next report 2026-08-06, last quarter miss, P/E -6.45. Updated 2026-07-23.
Sensus Healthcare (SRTS) Research Hub
Sensus Healthcare (SRTS) trades on NASDAQ, US in the Healthcare (Medical - Devices) sector. As of 2026-10-26, shares last closed at 2.82 USD (-4.41%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -6.45, market cap 0.05B. This hub links to the full technical, earnings and options research available for SRTS.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Devices) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 2.82 USD (-4.41%) |
| 52-week range | 2.68 USD – 3.65 USD |
| Trend regime | Range |
| 14-day RSI | 37.7 (Bearish) |
| Trailing P/E | -6.45 |
| Market cap | 0.05B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-06 |
Available research for SRTS
Covered Call on SRTS: how it works, illustrative setup around the real 2.82 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on SRTS: how it works, illustrative setup around the real 2.82 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on SRTS: how it works, illustrative setup around the real 2.82 USD price, max profit/loss, breakeven and when to use it. Educational.
SRTS technical analysis: range, last 2.82 USD, RSI 37.7, 52w range 2.68 USD–3.65 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is SRTS in?
Sensus Healthcare (SRTS) is classified under Healthcare (Medical - Devices), listed on NASDAQ, US.
Is SRTS in an uptrend or downtrend?
As of 2026-10-26, SRTS is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is SRTS's trailing P/E ratio?
SRTS's trailing P/E is -6.45, with a market cap of 0.05B. See the earnings research page for full valuation detail.
When does SRTS next report earnings?
SRTS is next scheduled to report earnings on 2026-08-06.